Richa Rathore

Cisplatin exposure causes c-Myc-dependent resistance to CDK4/6 inhibition in HPV-negative head and neck squamous cell carcinoma

Anthony M. Robinson, Richa Rathore, Nathan Redlich et al. · Cell Death and Disease · 2019 · 63 citations · Full text

Arginine Starvation and Docetaxel Induce c-Myc–Driven hENT1 Surface Expression to Overcome Gemcitabine Resistance in ASS1-Negative Tumors

Bethany C. Prudner, Richa Rathore, Anthony M. Robinson et al. · Clinical Cancer Research · 2019 · 61 citations · Full text

PHGDH as a mechanism for resistance in metabolically-driven cancers

Richa Rathore, Charles R. Schutt, Brian A. Van Tine · Cancer Drug Resistance · 2020 · 47 citations · Full text

Tumor Biology, Phgdh-driven Resistance, Biochemistry +14

Metabolic compensation activates pro-survival mTORC1 signaling upon 3-phosphoglycerate dehydrogenase inhibition in osteosarcoma

Richa Rathore, Katharine E. Caldwell, Charles R. Schutt et al. · Cell Reports · 2021 · 46 citations · Full text

Rapamycin Complex 1, Metabolic Remodeling, Pro-survival Mtorc1 +19

Targeted delivery of gold nanoparticle contrast agents for reporting gene detection by magnetic resonance imaging

Luke Vistain, Matthew W. Rotz, Richa Rathore et al. · Chemical Communications · 2015 · 31 citations